Global Cell Lysis Market 2017-2021
About Cell Lysis
Cells are considered as the basic unit of life. The study of different cell structures is called cell biology. The understanding of cells and their components is crucial as several patterns can be observed and several compounds can be discovered. This could contribute to the discovery of new treatments or advancements of existing treatments. Cell biology can also help increase target population and enhance the mechanism of action (MOA) to reduce treatment time.Technavio’s analysts forecast the global cell lysis market to grow at a CAGR of 7.54% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global cell lysis market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of instruments and consumables that are used for cell lysis.The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Cell Lysis Market 2017-2021
Technavio recognizes the following companies as the key players in the global cell lysis market: Bio-Rad Laboratories, Beckman Coulter, Merck Millipore, and Thermo Fisher Scientific.
Other Prominent Vendors in the market are: Becton, Dickinson and Company, Cell Signaling Technology, F. Hoffmann–La Roche, Miltenyi Biotec, Omni International, Qiagen, and Qsonica.
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is emergence of unique methods of cell disruption. As the prevalence of several unique diseases has increased globally, researchers must look toward innovation. Chronic diseases such as hepatitis B and human immunodeficiency virus (HIV) have caused the deaths of millions of people across the world. However, no cure for these diseases has been discovered.”
According to the report, one driver in the market is expanding biotechnology industry. Cell lysis is a critical part of protein extraction. This is because the components of a cell can only be examined after they have been exposed from the protection of the outer membrane. Once the component of a cell is analyzed and the compound of interest is discovered, it can be developed into a drug. This indicates the contribution of cell lysis, which is an essential prerequisite step, to drug discovery. Cell lysis techniques are leveraged by biotechnology companies for protein or nucleic acid research.
Further, the report states that one challenge in the market is excessive cost of cell-based research. Cell lysis is an essential part of any cell-based research process as the components of a cell can only be studied when the exterior components of a cell have been sufficiently lysed. Proteins, which are essential components to understand cellular structures and functions, can only be extracted after a successful cell lysis. Additionally, as proteins are heterogeneous, one method of cell lysis cannot be applied universally. The lysis process also depends on the cell type.
Bio-Rad Laboratories, Beckman Coulter, Merck Millipore, Thermo Fisher Scientific, Becton, Dickinson and Company, Cell Signaling Technology, F. Hoffmann–La Roche, Miltenyi Biotec, Omni International, Qiagen, and Qsonica.